CD4 and Familial prostate cancer: However, in patients with prostate cancer undergoing radiotherapy before treatment initiation, there was no significant effect on the percentage of CD4+ and CD8+ T lymphocytes, Tregs, NK or NKT cell subsets at the end of radiotherapy.